This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Biosimilars
Biosimilars
Biosimilar Remicade® – the cost-saving benefits
Sandoz launches Zarxio (TM) (filgrastim-sndz), the first biosimilar in the United States
At the dawn of biosimilar insulins
First biosimilar monoclonal antibody distribution licence secured
France biosimilar substitution plan progresses
Biosimilars in dermatology
Clinical trial design and development of biosimilars
Regulatory challenges for biosimilar mAbs
Phase III clinical trial for biosimilar etanercept
Generics and biosimilars in Central and Eastern Europe
Antibody biosimilars: fears or opportunities?
EMA to accept biosimilar reference medicines sourced outside EEA
« Previous
1
2
3
4
5
…
8
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: